These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 36084758)

  • 1. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors.
    Engler J; Filliter C; Montastruc F; Abenhaim H; Rej S; Renoux C
    J Affect Disord; 2024 Apr; 350():813-821. PubMed ID: 38246277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale observational comparison of antidepressants and their effects.
    Heinz MV; Yom-Tov E; Mackin DM; Matsumura R; Jacobson NC
    J Psychiatr Res; 2024 Oct; 178():219-224. PubMed ID: 39163659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
    JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
    Nephrol Dial Transplant; 2022 Oct; 37(11):2241-2252. PubMed ID: 35793567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
    Czaja AS; Valuck RJ; Anderson HD
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
    Nichols AL; Blumenfeld Z; Luebbert L; Knox HJ; Muthusamy AK; Marvin JS; Kim CH; Grant SN; Walton DP; Cohen BN; Hammar R; Looger L; Artursson P; Dougherty DA; Lester HA
    J Neurosci; 2023 Mar; 43(13):2222-2241. PubMed ID: 36868853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
    Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
    JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of selective serotonin reuptake inhibitors.
    Hiemke C; Härtter S
    Pharmacol Ther; 2000 Jan; 85(1):11-28. PubMed ID: 10674711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE; Venton BJ
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.